
Hydrocodone
Once-daily hydrocodone (Hysingla ER) reduced chronic low back pain more than placebo in a 12-week trial of people who already tolerated it. For short-term pain, hydrocodone with acetaminophen did not beat ibuprofen with acetaminophen after wisdom tooth removal or for acute limb pain. Alcohol is the main drink interaction, and the boxed warning stresses that alcohol with hydrocodone can be fatal.
Prescription medication: not a dietary supplement
This is an FDA-approved (or investigational) drug, not a supplement. It requires a prescription and medical supervision. The information below summarizes clinical-trial evidence for education only. It is not a recommendation to obtain or use it without a doctor.
Quick decision guide
May help most
Adults with pain severe enough to need an opioid when other treatments are inadequate (combination tablets), or with severe, persistent pain that other options, including immediate-release opioids, cannot treat (Hysingla ER), under a prescriber
Common dosing range
Set by a prescriber. Hydrocodone and acetaminophen 5 mg/325 mg tablets start at 1 to 2 tablets every 4 to 6 hours as needed, up to 8 tablets a day. Hysingla ER starts at 20 mg once every 24 hours in people not already taking opioids.
When to expect effects
Immediate-release hydrocodone peaked in the blood about 1.3 hours after a dose; Hysingla ER peaks about 14 to 16 hours after a dose and reaches steady levels by day 3
Watch out for
Boxed warnings for addiction, abuse and misuse; life-threatening breathing problems; fatal accidental ingestion; profound sedation, coma and death with benzodiazepines, other sedating drugs or alcohol; neonatal opioid withdrawal syndrome; and fatal overdose when CYP3A4 blockers are added or CYP3A4 inducers are stopped. Hysingla ER tablets must be swallowed whole. Combination products carry an acetaminophen liver warning.
What is it
Hydrocodone is a prescription opioid pain medicine and a Schedule II controlled substance. In the US it is sold mostly combined with acetaminophen, as hydrocodone bitartrate and acetaminophen tablets and liquids (including Norco and many generics), taken every 4 to 6 hours as needed for pain severe enough to need an opioid when other treatments are inadequate. The single-ingredient form is Hysingla ER, an extended-release tablet taken once every 24 hours for severe and persistent pain that cannot be treated adequately with other options, including immediate-release opioids; it is not for as-needed use. In combination products the acetaminophen counts toward your total daily acetaminophen, and the label warns that most liver injury happens above 4,000 mg of acetaminophen a day, often from more than one acetaminophen product. Every hydrocodone label carries the opioid boxed warning. Statements on this page come from the Hysingla ER label unless another label is named.
Is it worth it for you?
Use this as a quick fit check, not a diagnosis.
Worth considering if…
Probably skip if…
Evidence at a glance
| Goal | Effect | Best fit | Time |
|---|---|---|---|
pain after wisdom tooth removal Good Evidence | None; ibuprofen with acetaminophen was 0.70 points better on day 1 | Not applicable; no advantage over a non-opioid combination was found | Measured over the postoperative period |
acute limb pain in the emergency department Good Evidence | None vs ibuprofen plus acetaminophen; pain fell 3.5 vs 4.3 points at 2 hours | Not applicable; no advantage over a non-opioid combination was found | Measured 2 hours after one dose |
chronic low back pain (once-daily hydrocodone, Hysingla ER) Limited Evidence | Statistically significant pain reduction vs placebo at 12 weeks in people who had already responded | Adults with severe, persistent low back pain who already tolerate and respond to hydrocodone | Measured at 12 weeks after randomization |
chronic back pain or hip or knee osteoarthritis pain Limited Evidence | None for function; pain intensity 0.5 points worse than non-opioid medicines | Not applicable; no advantage over non-opioid medicines was found | Measured over 12 months |
pain after wisdom tooth removal
- Effect
- None; ibuprofen with acetaminophen was 0.70 points better on day 1
- Best fit
- Not applicable; no advantage over a non-opioid combination was found
- Time
- Measured over the postoperative period
acute limb pain in the emergency department
- Effect
- None vs ibuprofen plus acetaminophen; pain fell 3.5 vs 4.3 points at 2 hours
- Best fit
- Not applicable; no advantage over a non-opioid combination was found
- Time
- Measured 2 hours after one dose
chronic low back pain (once-daily hydrocodone, Hysingla ER)
- Effect
- Statistically significant pain reduction vs placebo at 12 weeks in people who had already responded
- Best fit
- Adults with severe, persistent low back pain who already tolerate and respond to hydrocodone
- Time
- Measured at 12 weeks after randomization
chronic back pain or hip or knee osteoarthritis pain
- Effect
- None for function; pain intensity 0.5 points worse than non-opioid medicines
- Best fit
- Not applicable; no advantage over non-opioid medicines was found
- Time
- Measured over 12 months
Evidence for 4 uses
AI-assisted evidence assessment. Talk to your doctor before relying on any single supplement.
pain after wisdom tooth removal
No benefit foundA multisite, double-blind randomized noninferiority trial in 1,815 adults having impacted lower wisdom teeth removed compared hydrocodone 5 mg with acetaminophen 300 mg against ibuprofen 400 mg with acetaminophen 500 mg, taken every 4 to 6 hours as needed. People on the non-opioid combination had less pain on the first day and night (by 0.70 points on a 0 to 10 scale) and the second day and night (by 0.28 points), no more pain over the whole recovery, and higher satisfaction (85.3% versus 78.9% extremely satisfied or satisfied). At no time did hydrocodone do better.
Bottom line: After wisdom tooth removal, ibuprofen with acetaminophen relieved pain better than hydrocodone with acetaminophen in the first 2 days.
acute limb pain in the emergency department
No benefit foundA randomized trial at 2 emergency departments in the Bronx, New York, gave 416 adults aged 21 to 64 with moderate to severe acute arm or leg pain one of four single doses. After 2 hours, pain on a 0 to 10 scale fell by 3.5 points with 5 mg hydrocodone plus 300 mg acetaminophen and by 4.3 points with 400 mg ibuprofen plus 1,000 mg acetaminophen. Starting pain averaged 8.7. The overall difference between the four groups was not statistically significant (P = .053), and no difference reached the 1.3-point minimum the investigators had set as clinically important. Side effects were not assessed, and only one dose was studied.
Bottom line: For acute arm or leg pain, hydrocodone with acetaminophen was not better than ibuprofen with acetaminophen.
chronic low back pain (once-daily hydrocodone, Hysingla ER)
Disease adjunctIn a multicenter trial behind the Hysingla ER approval, 905 adults with uncontrolled moderate to severe chronic low back pain took once-daily hydrocodone in an open-label phase to find a dose. The 588 (65%) who got good relief and tolerated it were then randomized to keep taking it (20 to 120 mg a day, average 57 mg) or to switch to a placebo. At 12 weeks, pain was lower in the hydrocodone group (p = 0.0016), and more people kept at least a 30% or 50% improvement. Because only people who already responded were randomized, the trial shows that the benefit lasts in responders rather than how many new patients will benefit.
Bottom line: In people who already responded to it, once-daily hydrocodone kept chronic back pain lower than switching to placebo over 12 weeks.
chronic back pain or hip or knee osteoarthritis pain
No benefit foundThe SPACE trial randomized 240 US veterans (mean age 58.3, 13.0% women) with moderate to severe chronic back pain or hip or knee arthritis pain to an opioid strategy or a non-opioid strategy for 12 months. The opioid group started on immediate-release morphine, oxycodone or hydrocodone with acetaminophen; the non-opioid group started on acetaminophen or an anti-inflammatory drug. Pain-related function did not differ (3.4 versus 3.3 on a 0 to 10 scale), pain intensity was slightly better without opioids (4.0 versus 3.5), and medication-related symptoms were more common with opioids (1.8 versus 0.9 on a 0 to 19 checklist at 12 months). Hydrocodone was one of several opioid options, so the trial tests opioid treatment in general.
Bottom line: Over a year, opioids including hydrocodone did not improve daily function more than non-opioid pain medicines for back or arthritis pain.
How it works
How to take it
What to track
Bottom line: A prescriber sets the dose; do not drink alcohol, count every acetaminophen product, and tell your prescriber about every sedating medicine and any new prescription.
Safety
Know the common side effects, key cautions, and who should avoid it.
Common side effects
Serious risks
Boxed warning: addiction, abuse and misuse, which can lead to overdose and death; the label asks prescribers to assess each person's risk before prescribing and to reassess regularly.
Boxed warning: serious, life-threatening or fatal breathing problems (respiratory depression), especially when starting or after a dose increase. Hysingla ER tablets must be swallowed whole; crushing, chewing or dissolving them can release a potentially fatal dose.
Boxed warning: accidental ingestion of even one dose, especially by children, can cause a fatal overdose of hydrocodone.
Boxed warning: using opioids with benzodiazepines or other central nervous system depressants, including alcohol, may cause profound sedation, respiratory depression, coma and death; such combinations are reserved for people whose other options are inadequate.
Boxed warning: neonatal opioid withdrawal syndrome. Long-term use during pregnancy can cause withdrawal in the newborn, which may be life-threatening if not recognized and treated.
Boxed warning: Opioid Analgesic REMS. Prescribers are strongly encouraged to complete REMS education and to counsel patients and caregivers on serious risks, safe use and reading the Medication Guide with each prescription.
Boxed warning: cytochrome P450 3A4 interaction. Using hydrocodone with any CYP3A4 inhibitor, or stopping a CYP3A4 inducer, may raise hydrocodone levels and cause potentially fatal respiratory depression.
Combination products: the hydrocodone and acetaminophen label carries a boxed warning for liver toxicity. Acetaminophen has been linked to acute liver failure, sometimes needing a transplant or causing death; most cases involved more than 4,000 mg of acetaminophen a day, often from more than one acetaminophen product.
Hysingla ER: QTc prolongation (a change in heart rhythm) seen at 160 mg a day, so it is avoided in people with congenital long QT syndrome; difficulty swallowing the tablet, including choking, was reported by 11 of 2,476 trial participants.
Who should avoid it
- People with significant breathing depression, acute or severe asthma without monitoring and resuscitation equipment, known or suspected bowel blockage including paralytic ileus, or a known allergy to hydrocodone (contraindicated)
- People taking an MAOI (such as phenelzine, tranylcypromine or the antibiotic linezolid) or within 14 days of stopping one: the label says Hysingla ER is not recommended and to avoid the combination
- Older adults and people with liver or kidney impairment, who may have higher hydrocodone levels and need lower starting doses and close monitoring
Pregnancy & breastfeeding
Pregnancy: the Hysingla ER label says long-term opioid use during pregnancy may cause neonatal opioid withdrawal syndrome, and that available data are not enough to show whether hydrocodone raises the risk of major birth defects or miscarriage. Animal studies showed no birth defects, but reduced pup survival and body weight at doses toxic to the mother. Opioids cross the placenta, and Hysingla ER is not recommended during or just before labor. Breastfeeding: hydrocodone and its active metabolite hydromorphone pass into breast milk in variable amounts. Because of the potential for excess sleepiness and breathing problems in the infant, the Hysingla ER label says breastfeeding is not recommended during treatment.
Interactions
The hydrocodone boxed warning says opioids combined with alcohol may cause profound sedation, slowed breathing, coma and death, and the Hysingla ER Medication Guide says not to drink alcohol or use medicines that contain alcohol, because doing so may cause you to overdose and die. An older label for a different extended-release product, Zohydro ER capsules (2015 version), reported that taking a 50 mg capsule with 40% alcohol on an empty stomach raised peak hydrocodone levels 2.4-fold on average; the current Hysingla ER label does not report such a study for its tablets. In hydrocodone and acetaminophen products, alcohol also raises the risk of acetaminophen liver injury. Do not drink while taking hydrocodone, and tell your prescriber if avoiding alcohol is hard.
Boxed warning: combining hydrocodone with benzodiazepines or other central nervous system depressants, which the label lists as including sedatives, muscle relaxants, antipsychotics, gabapentinoids and other opioids, may cause profound sedation, slowed breathing, coma and death. In an observational study of US veterans (mostly men) on opioid pain medicines in 2004 to 2009, a current benzodiazepine prescription was linked to 3.86 times the risk of overdose death compared with no benzodiazepine prescription, an association rather than proof of cause. The gabapentin label adds that a 500 mg gabapentin dose lowered hydrocodone peak levels and exposure by 21% to 22% in a small study, for unknown reasons.
Boxed warning: these changes can raise hydrocodone levels and cause potentially fatal breathing problems. In a label study, ketoconazole raised hydrocodone exposure by 135% and peak levels by 78%. The label asks prescribers to evaluate people regularly when any CYP3A4 inhibitor or inducer is started or stopped. Tell every prescriber and pharmacist that you take hydrocodone.
Documented interactions
Evidence-graded pair pages with sources, dosing notes, and timing guidance, a complement to the narrative section above.
See all 1 Hydrocodone interaction →Choosing a product
What to look for on the label, and what to be skeptical of.
Look for…
Be skeptical of…
Frequently asked questions
Can I drink alcohol while taking hydrocodone?⌄
No. The boxed warning says opioids with alcohol may cause profound sedation, slowed breathing, coma and death, and the Medication Guide says not to drink alcohol or use medicines that contain alcohol during treatment. In hydrocodone and acetaminophen products, alcohol also raises the risk of liver injury.
Can I take Tylenol or another acetaminophen product with hydrocodone and acetaminophen tablets?⌄
Check with your pharmacist first. The acetaminophen in these tablets counts toward your daily total, and the label warns that most liver injury happens above 4,000 mg of acetaminophen a day, often from more than one acetaminophen product. Look for acetaminophen or APAP on every label.
Can I take gabapentin or a sleep aid with hydrocodone?⌄
Only if your prescriber has weighed the risk. The boxed warning says hydrocodone with benzodiazepines or other sedating drugs, including alcohol, may cause profound sedation, slowed breathing, coma and death, and the label's warnings section names gabapentin and pregabalin among those drugs. The label asks prescribers to discuss access to an overdose reversal medicine such as naloxone.
Is hydrocodone stronger than ibuprofen for dental pain?⌄
Not in a large trial. After wisdom tooth removal, ibuprofen with acetaminophen relieved pain better than hydrocodone with acetaminophen for the first 2 days and left people more satisfied. Discuss pain options with your dentist or doctor.
Can other medicines change how strong hydrocodone is?⌄
Yes. Medicines that block the liver enzyme CYP3A4, such as some antibiotics and antifungals, can raise hydrocodone to dangerous levels; ketoconazole more than doubled exposure in a label study. Stopping a drug that speeds up that enzyme can do the same. Tell every prescriber and pharmacist that you take hydrocodone.
References by claim
chronic low back pain (once-daily hydrocodone, Hysingla ER)
Wen et al., 2015 · PubMed (2015) link
pain after wisdom tooth removal
Feldman et al., 2025 · PubMed (2025) link
acute limb pain in the emergency department
Chang et al., 2017 · PMC (2017) link
chronic back pain or hip or knee osteoarthritis pain
Krebs et al., 2018 · PMC (2018) link
Safety
Interaction: Alcohol
Track Hydrocodone with Pilora
Set up dose reminders, check interactions, and join the community in the Pilora app.
Disclaimer: This page summarizes published clinical-trial data for educational purposes and is not medical advice or a recommendation to use this prescription medication. Dosing, eligibility, and monitoring must be decided by a licensed prescriber.
